Australia · Delayed Price · Currency is AUD Lycopodium Earnings Call Transcripts
Fiscal Year 2026
-
Revenue and NPAT met targets with a 10.5% margin, supported by a strong order book and pipeline. Project delays impacted forecasts, but utilization and demand are expected to rise, especially in the Americas and Middle East. Guidance remains robust for the full year.
Fiscal Year 2025
-
Delivered strong financial results with revenue and NPAT at the top end of guidance, driven by robust project delivery and geographic expansion. Maintained high margins, strong cash flow, and a disciplined risk approach, with a positive outlook supported by a diversified project pipeline.
-
Strong half-year results with robust revenue and earnings, driven by EPCM services and strategic acquisition of Saxum, expanding global reach and sector expertise. FY25 guidance reflects solid revenue and EBITDA, with a balanced project portfolio and continued focus on operational excellence.
Fiscal Year 2024
-
Record revenue and profit were achieved in FY 2024, with strong performance in mineral resources, robust safety metrics, and a growing global footprint. Outlook remains positive, driven by energy transition demand and continued expansion in infrastructure and industrial processes.